Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

Akero Therapeutics (AKRO) reported 96-week data in its trial of advanced MASH patients, and there seem really significant ...

Shares of Akero Therapeutics ($AKRO) skyrocketed on Monday following game-changing results from its lead drug, efruxifermin, ...

Conflicting studies make it difficult to understand how drinking in moderation might impact your health.Moderate drinking—one ...

A dietary supplement used to build muscle – or prevent muscle loss as a result of ageing or illness – is to be trialled as a potential treatment for chronic liver disease.

Major barriers in screening for fatty liver disease in patients with HIV included uncertainties about testing, diagnostic ...

Have you been diagnosed with fatty liver disease? Here are the top 10 foods that you must avoid eating right now to control ...

RESIDENTS across the town are being urged to ‘love their liver’ after it was revealed that more than 400 adm... Local News ...

In recent health developments, Akero Therapeutics' drug shows promise for liver disease, Eisai/Biogen's Alzheimer's drug ...

Propofol has proven effective in liver transplantation procedures for both initiating and sustaining anesthesia. Compared to ...